Flamenbaum W, Gagnon J, Ramwell P
Am J Physiol. 1979 Dec;237(6):F433-40. doi: 10.1152/ajprenal.1979.237.6.F433.
The present studies examined the role of the renin-angiotensin system as a modifier of the renal vasomotor response to bradykinin. Renal arterial bradykinin infusion (80 ng.kg-1.min-1) initially resulted in increased renal blood flow (RBF). The secretory rates of renin and prostaglandins increased after 60 min. With continued bradykinin administration (120 min) RBF and prostaglandin secretory rates returned toward control values, although renin secretory rate remained elevated (P less than 0.02). After prostaglandin synthetase inhibition, RBF decreased and bradykinin administration returned RBF to control values. Prostaglandin secretory rates decreased after meclofenamate (P less than 0.005). Continued bradykinin infusion resulted in a return of the renin secretory rate to control values. The administration of bradykinin after competitive inhibition of angiotensin II resulted in a sustained increase in renal blood flow. These results suggest that the initial bradykinin-induced renal hyperemia is only partially dependent on enhanced prostaglandin release, the increase in renin secretion by bradykinin infusion after prostaglandin synthetase inhibition is consistent with a bradykinin and renin interaction, and the lack of a sustained hyperemia after bradykinin is related to increased renin-angiotensin system activity.
本研究探讨了肾素-血管紧张素系统作为缓激肽肾血管舒缩反应调节因子的作用。肾动脉输注缓激肽(80 ng·kg-1·min-1)最初导致肾血流量(RBF)增加。60分钟后肾素和前列腺素的分泌率升高。持续给予缓激肽(120分钟)后,RBF和前列腺素分泌率恢复至对照值,尽管肾素分泌率仍升高(P<0.02)。前列腺素合成酶抑制后,RBF降低,给予缓激肽后RBF恢复至对照值。甲氯芬那酸后前列腺素分泌率降低(P<0.005)。持续输注缓激肽导致肾素分泌率恢复至对照值。血管紧张素II竞争性抑制后给予缓激肽导致肾血流量持续增加。这些结果表明,最初缓激肽诱导的肾充血仅部分依赖于前列腺素释放增加,前列腺素合成酶抑制后缓激肽输注导致肾素分泌增加与缓激肽和肾素相互作用一致,缓激肽后缺乏持续充血与肾素-血管紧张素系统活性增加有关。